Author response for "Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline <scp>glycated haemoglobin level</scp> in Japanese patients with type 2 diabetes: A subgroup analysis of the <scp>SURPASS</scp> J‐mono study"
crossref（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要